Skip to main content
Caplight Logo









Ivy Natal

Ivy Natal

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://ivynatal.com

Last Round

Accelerator

Oct 27, 2020

Total Funding Raised

$250,000

Company Overview

Ivy Natal is a biotechnology company developing a novel process to create healthy human egg cells from skin cells to address infertility.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

in vitro gametogenesisIVGreproductive biotechnologystem cell reprogrammingfertility technologylab-grown eggsinfertility treatmentcomputational biologyprecision medicineregenerative medicinebiotech startupegg freezing alternativeassisted reproductionsynthetic biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ivy Natal Comparables

Compare Ivy Natal with similar companies based on industry and business-model similarity.

Ivy Natal comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ovelle Bio Corp.
91%
Conception
90%
Vitra Labs
88%

Ivy Natal Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorOct 27, 2020

Ivy Natal Investors

Notable investors and investment history

Ivy Natal investors
InvestorRounds
IndieBioAccelerator
SOSVAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 19, 2025

    Monthly visitors increased 84% MoM.

Ivy Natal Filings

Explore SEC and related filing metadata, where available.

Ivy Natal filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ivy Natal's valuation, stock price, and market status.

Is Ivy Natal a public or private company?

Ivy Natal is a private company.

What is the current stock price of Ivy Natal?

Ivy Natal is a private company with no public stock price. No recent secondary market data is available.

How much is Ivy Natal worth (valuation)?

Valuation information for Ivy Natal is not publicly available.

Can I buy Ivy Natal stock?

Ivy Natal shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ivy Natal's last funding round?

Ivy Natal's most recent funding round was Accelerator on October 27, 2020.

Who are the main investors in Ivy Natal?

Key investors in Ivy Natal include IndieBio, SOSV.

Will Ivy Natal IPO soon?

No public IPO plans have been announced for Ivy Natal.

How can I track Ivy Natal secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ivy Natal's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range1
Year Founded2020
Last FundingOct 27, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?